The Mechanism of Plantaginis Semen in the Treatment of Diabetic Nephropathy based on Network Pharmacology and Molecular Docking Technology

被引:2
|
作者
He, Linlin [1 ]
Shen, Kai [1 ,2 ]
He, Lei [1 ]
Chen, Yuqing [1 ]
Tang, Zhiyuan [1 ]
机构
[1] Nantong Univ, Affiliated Hosp, Dept Pharm, Nantong 226001, Peoples R China
[2] Nanjing Univ Chinese Med, Coll Pharm, Nanjing 210023, Peoples R China
关键词
Plantaginis semen; diabetic nephropathy; network pharmacology; molecular docking; CASP3; quercetin; DRUG TARGET IDENTIFICATION; WEB SERVER; QUERCETIN; DAMAGE; PREDICTION; SPECTRUM; PROVIDES; DISEASES; KIDNEY; LEVEL;
D O I
10.2174/1871530323666230915100355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Diabetic nephropathy (DN) is one of the common complications of diabetes. Plantaginis Semen (PS) has a variety of therapeutic effects, however its mechanism on DN is unclear.Objective This paper aims to find the ingredients, the key targets, and the action pathways of PS on DN from the perspective of network pharmacology.Methods The databases of network pharmacology, such as Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Pharmmapper, OMIM, DrugBank, GeneCards, TTD, Disgenet, STRING, and Cytoscape software, were used to find the main ingredients and targets. Gene Ontology (GO) function and Kyoto Encyclopedia of Genome and Genomes (KEGG) pathway enrichment analysis were used to reveal the potential pathways of the PS on DN. The GEO database was used to find the targets of DN based on valid experimental research. The molecular docking technology was used to evaluate the combination between ingredients of PS and the targets.Results A total of 9 active ingredients and 216 potential therapeutic targets were obtained for PS on DN. Hub targets were discovered by the Cytoscape software analysis. CASP3 was screened by Venn diagram by making intersection between GSE30529 and hub genes. Moreover, CASP3 was combined with one of the nine active ingredients, quercetin, by molecular docking analysis. The KEGG pathways were mainly involved in diabetic nephropathy, and were simultaneously associated with CASP3 as followed: AGE-RAGE signaling pathway in diabetic complications, apoptosis, lipid and atherosclerosis, MAPK signaling pathway, TNF signaling pathway, IL-17 signaling pathway, and p53 signaling pathway.Conclusion PS can have the treatment on DN through CASP3. Quercetin, as one of the nine active ingredients, can be bounded to CASP3 to inhibit apoptosis in DN. PS can also take action on DN probably through many pathways. The role of PS on DN through other pathways still needs to be further elaborated.
引用
收藏
页码:363 / 379
页数:17
相关论文
共 50 条
  • [1] Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
    Hu, Yaling
    Liu, Shuang
    Liu, Wenyuan
    Zhang, Ziyuan
    Liu, Yuxiang
    Li, Sufen
    Sun, Dalin
    Zhang, Guang
    Fang, Jingai
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 943 - 962
  • [2] Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology
    Shen, Li
    Lu, Jinmiao
    Wang, Guangfei
    Wang, Cheng
    Li, Zhiping
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [3] Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology
    Yankai Dong
    Bo Tao
    Xing Xue
    Caixia Feng
    Yating Ren
    Hengyu Ma
    Junli Zhang
    Yufang Si
    Sisi Zhang
    Si Liu
    Hui Li
    Jiahao Zhou
    Ge Li
    Zhifei Wang
    Juanping Xie
    Zhongliang Zhu
    BMC Complementary Medicine and Therapies, 21
  • [4] Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular docking technology
    Dong, Yankai
    Tao, Bo
    Xue, Xing
    Feng, Caixia
    Ren, Yating
    Ma, Hengyu
    Zhang, Junli
    Si, Yufang
    Zhang, Sisi
    Liu, Si
    Li, Hui
    Zhou, Jiahao
    Li, Ge
    Wang, Zhifei
    Xie, Juanping
    Zhu, Zhongliang
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2021, 21 (01)
  • [5] Exploring the targets and molecular mechanism of glycyrrhetinic acid against diabetic nephropathy based on network pharmacology and molecular docking
    Meng, Fan-Di
    Yuan, Ling
    Xu, Duo-Jie
    Che, Meng-Ying
    Hou, Shao-Zhang
    Lu, Dou-Dou
    Liu, Wen-Jing
    Nan, Yi
    WORLD JOURNAL OF DIABETES, 2023, 14 (11) : 1672 - 1692
  • [6] Study on the Therapeutic Mechanism of Sanhuang Xiexin Decoction on Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
    Chen, Ying
    Qian, Liting
    Guan, Jing
    Liu, Pengju
    Yu, Cheng
    Song, Danning
    Jiang, Shuang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (07): : 1515 - 1522
  • [7] Network pharmacology and molecular docking technology-based predictive study and potential targets analysis of icariin for the treatment of diabetic nephropathy
    Chen, Min
    Zhou, Yujie
    Yang, Jianglin
    Yuan, Huixiong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 751
  • [8] Network pharmacology, molecular docking, and experimental verification to reveal the mechanism of colquhounia root tablet in the treatment of diabetic nephropathy
    Chen, Dandan
    Wang, Simeng
    Sun, Zhikang
    Zhang, Xinyu
    Chong, Nannan
    Shu, Jianqiang
    Wang, Qinglian
    Xu, Ying
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 745
  • [9] Based on Network Pharmacology and Molecular Docking to Explore the Underlying Mechanism of Huangqi Gegen Decoction for Treating Diabetic Nephropathy
    Ding, Shanshan
    Wang, Weihao
    Song, Xujiao
    Ma, Hao
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [10] Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy
    Fu, Shaojie
    Zhou, Yena
    Hu, Cong
    Xu, Zhonggao
    Hou, Jie
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)